Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,773
Recruiting: 1,496
Ph III recruiting: 183
Growth YoY: +7.3%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,526)

clinicaltrialsPublishedShowing 151–155 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00099541	Non-small Cell Lung Cancer Registry	completed	Phase 4	300	Novartis PharmaceuticalsINDUSTRY	1	Nov 23, 2009	clinicaltrials
NCT00115206	Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy	completed	Phase 4	—	AmgenINDUSTRY	0	Apr 6, 2009	clinicaltrials
NCT00675168